Cambridge Healthtech Institute

Visit numerous concurrent sessions for informative presentations, lively dialogue, and meaningful connections with fully vaccinated peers. Customize your experience further through focused short courses, interactive discussions, and networking options.

Cambridge Healthtech Institute’s conference on Artificial Intelligence in Drug Discovery. Experts will discuss the increasing use of AI for target discovery, drug design and biomarker discovery. It will bring together chemists, biologists, pharmacologists and bioinformaticians from around the world.

The prevalence of fibrosis as a disease state continues to grow. NASH (non-alcohol steatohepatitis) has become an area of increased drug development. Cambridge Healthtech Institute’s NASH and Fibrosis conference shines a spotlight on NASH.

PepTalk connects protein science researchers from around the world to share ideas and solve problems. This year’s event will comprise 5 days of programming featuring 17 conferences, 4 training seminars and 275 speakers.

Peptalk’s Intelligent Antibody Discovery conference examines the technologies, informatics, and strategies driving a move to improve the quality, precision, and developability of biotherapeutic selections. Part One examines new capabilities of NGS and repertoire sequencing tools, and the challenges of developing...

The Cell Line Engineering and Development conference explores ways to make biology easier to “engineer”. Learn from seasoned, savvy researchers as they share their real-world experiences, applications, and results.

This conference is part of the Cell & Gene Therapy Pipeline that also features the 4th Annual Cell Therapy Analytics & Manufacturing conference and a training seminar on Introduction to CMC for Biotech, Cell & Gene Therapy Products.

This conference is part of the Characterization of Biotherapeutics & Vaccines Pipeline which also features the 9th Annual Characterization of Biotherapeutics conference and the inaugural Characterization and Development of Vaccines.

Peptalk’s two-part Intelligent Antibody Discovery conference examines the technologies, informatics, and strategies driving a move to improve the quality, precision, and developability of biotherapeutic selections. Part One examines new capabilities of next-generation sequencing tools and strategies for developing high-throughput functional...

The Developability of Bispecific Antibodies conference examines the abundance and scope of bispecific antibody constructs. The meeting will span from discovery and engineering all the way through clinical development. It will examine how to identify molecules early in the development...